Their principal indication remains for the management of T2DM, with agents such as exenatide, liraglutide, dulaglutide, semaglutide, Lixisenatide, and tirzepatide approved to enhance glycemic control
The study of metabolic interventions has increasingly concentrated on the dynamics of cardiac fatty acid and glucose metabolism, along with mitochondrial oxidative capacity, as pivotal areas impacting cardiovascular health
#antipsychotics #clinicalresearch #digitalhealth #digitaltherapeutics #DTx #ECNP #healthtech #medicalaffairs To view or add a comment, sign in Uzedy: New FDA Approval for Bipolar I Disorder Im launching a monthly series highlighting new drug approvals and innovations in CNS, psychoactive molecules, and neuroscience
Yes, semaglutide can cause fatigue in some people who use the medication
Nguyen, D
Ahrn, B., Yamada, Y